293480.KS
Hana Pharm Co., Ltd. [293480.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
293480.KS Stock Summary
Top 10 Correlated ETFs
293480.KS
Top 10 Correlated Stocks
293480.KS
In the News
293480.KS Financial details
Company Rating
-
Market Cap
229.39B
Income
22.33B
Revenue
224.46B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
10.42
Forward P/E
-
PEG
-12.83
P/S
1.12
P/B
0.9
P/C
-
P/FCF
19.11
Quick Ratio
-
Current Ratio
1.71
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.29K
EPS next Y
-
EPS next Q
-
EPS this Y
-8.12%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.4%
Revenue last 5Y
6.18%
Revenue Q/Q
3.19%
EPS Q/Q
43.4%
-
-
-
-
SMA20
8.72%
SMA50
11.99%
SMA100
4.61%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
9%
ROC
0.1%
Gross Margin
63%
Oper. Margin
13%
Profit Margin
11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13170.0-16190.0
52W High
-28.6%
52W Low
-12.22%
RSI
67
Rel Volume
0.65
Avg Volume
21.84K
Volume
14.15K
Perf Week
2.21%
Perf Month
9.26%
Perf Quarter
2.03%
Perf Half Y
4.33%
-
-
-
-
Beta
0.474651
-
-
Volatility
57.68%, 444.21%
Prev Close
0%
Price
11560
Change
-1.03%
Company Profile
- Volume Average 21.84K
- Market Capitalization 229.39B
- CEO Taehong Choi
- Headquarters Seoul,KR
- IPO Date 2018-10-02
-
Website
https://www.hanaph.co.kr 
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.
